GO:0048525 negative regulation of viral process: Host Restriction Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048525 (negative regulation of viral process) describes any host or cellular process that stops, prevents, or reduces the frequency, rate, or extent of a viral multi-organism process.
• This GO term is a biological_process node that captures viral restriction at the level of the viral life cycle, including entry, replication, assembly, and release.
• Key effector mechanisms include post-translational modification of viral or host proteins, autophagy-mediated degradation, NF-kB signaling restriction, and negative regulation of cell death pathways such as PANoptosis and apoptosis.
• Central host regulators include A20 (TNFAIP3), ATG14, NS1 binding protein (NS1-BP/IVNS1ABP), and components of the canonical NF-kB pathway.
• Dysregulation of negative regulation of viral process contributes to viral pathogenesis, chronic infection, and virus-associated cancers.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to causally test whether candidate restriction factors truly negatively regulate viral processes.
Description
GO:0048525, negative regulation of viral process, is a Gene Ontology biological_process term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of a multi-organism process in which a virus is a participant. In practical terms, it encompasses the host cell's active restriction of viral life cycle steps, from entry and genome replication to assembly and release. This term is critical for researchers because it provides a standardized framework to annotate and compare host antiviral mechanisms across viruses and cell types. The process is not a single pathway but a collection of regulated events, including post-translational modifications of viral or host proteins, selective autophagy, and modulation of innate immune signaling. Understanding negative regulation of viral process is essential for dissecting host-pathogen interactions, identifying restriction factors, and developing host-directed antiviral strategies. Because many viruses have evolved countermeasures against these restriction mechanisms, the balance between negative regulation and viral evasion determines infection outcomes.
negative regulation of viral process At A Glance
| GO ID | GO:0048525 |
|---|---|
| GO term | negative regulation of viral process |
| Ontology | biological_process |
| Synonym | negative regulation of viral life cycle; inhibition of viral life cycle; downregulation of viral life cycle; negative regulation of viral reproduction |
| Major function | Host-mediated restriction of viral multi-organism processes, including entry, replication, assembly, and release |
| Definition source | QuickGO definition: Any process that stops, prevents, or reduces the frequency, rate or extent of a multi-organism process in which a virus is a participant |
| Related mechanisms | Post-translational modifications, autophagy, NF-kB signaling, PANoptosis, apoptosis regulation |
| Example regulators | A20 (TNFAIP3), ATG14, NS1 binding protein (IVNS1ABP), canonical NF-kB components |
| Disease relevance | Viral pathogenesis, chronic infection, virus-associated cancers, inflammatory disease |
What Is GO:0048525?
In our own words, GO:0048525 refers to any cellular or organism-level process that actively reduces, inhibits, or prevents a viral process, where a viral process is a multi-organism process involving a virus. This includes host restriction factors, immune signaling that limits viral replication, and cellular pathways that degrade viral components or block specific life cycle steps. The term is a biological_process and is synonymous with negative regulation of viral life cycle, inhibition of viral life cycle, and negative regulation of viral reproduction.
Why Is negative regulation of viral process Important in Cell Biology?
Negative regulation of viral process is important because it defines the host's ability to limit viral replication and spread, directly influencing infection outcomes, disease severity, and the development of virus-associated pathologies. Many viruses, such as hepatitis C virus and porcine deltacoronavirus, are sensitive to these restriction mechanisms, and their evasion strategies are key to pathogenesis. Understanding this process also informs the design of host-directed antivirals and immunotherapies that enhance endogenous restriction rather than targeting viral proteins directly.
• Defines host restriction mechanisms that limit viral entry, replication, assembly, and release.
• Provides a standardized GO annotation for comparing antiviral pathways across viruses and cell types.
• Central to understanding viral evasion and persistence, including chronic hepatitis C virus infection.
• Links to innate immune signaling, particularly canonical NF-kB and inflammatory pathways.
• Involves cell death regulation, including apoptosis and PANoptosis, which can either restrict or promote viral spread.
• Relevant to virus-associated cancers where negative regulators of apoptosis are hijacked by viruses.
• Guides identification of host-directed antiviral targets and biomarkers of infection outcome.
• Requires CRISPR-based causal validation to distinguish true restriction factors from correlative changes.
• Impacts autophagy and stress granule dynamics that control viral protein turnover.
• Informs vaccine and therapeutic strategies that aim to boost endogenous restriction.
What Happens During negative regulation of viral process?
Recognition and signaling initiation
In simple terms: The cell first senses the virus and turns on alarm signals that will later restrict it.
Negative regulation of viral process begins with host recognition of viral components, which activates signaling cascades such as the canonical NF-kB pathway. A20 (TNFAIP3) acts as a negative regulator of canonical NF-kB signaling, thereby modulating the intensity and duration of antiviral responses. Post-translational modifications of host and viral proteins are critical for regulating these restriction pathways, allowing rapid and reversible control of antiviral effectors. This step determines whether the cell mounts an effective restriction response or becomes permissive to infection.
Post-translational modification of restriction factors
In simple terms: Chemical tags are added to or removed from proteins to switch antiviral defenses on or off.
Regulation of viral restriction by post-translational modifications is a central mechanism in negative regulation of viral process. Phosphorylation, ubiquitination, SUMOylation, and other modifications control the stability, localization, and activity of restriction factors and viral proteins. These modifications can either enhance restriction or be exploited by viruses to evade host defenses. Understanding these events is essential for identifying druggable nodes in the restriction network.
Autophagy-mediated degradation of viral components
In simple terms: The cell's recycling system engulfs and destroys viral proteins or particles.
Autophagy contributes to negative regulation of viral process by targeting viral proteins and components for degradation. ATG14 targets lipid droplets and acts as an autophagic receptor for syntaxin18-regulated lipid droplet turnover, linking autophagy to lipid metabolism during viral restriction. Viral proteins are also regulated through autophagy, as reviewed in the context of viral protein turnover. This mechanism limits the availability of viral building blocks and can suppress replication.
Stress granule dynamics and clearance
In simple terms: The cell forms temporary storage granules that can trap viral RNA and proteins, then clears them.
NS1 binding protein (NS1-BP/IVNS1ABP) regulates stress granule dynamics and clearance by inhibiting p62 ubiquitination, which impacts the fate of viral and host proteins during infection. Stress granules can sequester viral RNA and modulate innate immune signaling, contributing to negative regulation of viral process. Dysregulation of this step can either enhance or impair viral restriction depending on context.
Negative regulation of cell death pathways
In simple terms: The cell controls how and when it dies, which can either stop viruses or help them spread.
A20 restricts porcine deltacoronavirus release through negative regulation of PANoptosis, a form of inflammatory cell death. Viral infections can also be influenced by negative regulators of apoptosis, which may be oncogenic factors in some contexts. Thus, negative regulation of viral process intersects with cell death machinery to determine whether infection is contained or disseminated.
Restriction of viral replication and release
In simple terms: The final steps of the viral life cycle are blocked so new viruses cannot be made or leave the cell.
Hepatitis C virus replication is subject to multiple layers of negative regulation by host factors, and understanding these steps is critical for antiviral development. A20-mediated restriction of PDCoV release demonstrates that negative regulation can act at the final stage of the viral life cycle. Together, these mechanisms reduce viral spread and are central to the GO:0048525 definition.
Key Genes Involved in GO:0048525 negative regulation of viral process
The following genes and proteins are experimentally implicated in negative regulation of viral process, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TNFAIP3 (A20) | Negative regulator of canonical NF-kB signaling and PANoptosis; restricts PDCoV release | Key restriction factor for coronavirus release and NF-kB-driven inflammation |
| ATG14 | Autophagic receptor for lipid droplet turnover via syntaxin18 | Links autophagy and lipid metabolism to viral restriction |
| IVNS1ABP (NS1-BP) | Regulates stress granule dynamics and clearance by inhibiting p62 ubiquitination | Controls viral RNA/protein fate during infection |
| NFKB1 | Core component of canonical NF-kB signaling modulated by A20 | Central to antiviral inflammatory signaling |
| NFKB2 | NF-kB pathway component involved in canonical signaling | Modulates antiviral gene expression |
| RELA | NF-kB transcription factor regulated by A20 | Drives antiviral and inflammatory gene programs |
| SQSTM1 (p62) | Ubiquitin-binding autophagy receptor regulated by NS1-BP | Controls stress granule clearance and viral protein turnover |
| STX18 (syntaxin18) | Regulates lipid droplet turnover with ATG14 | Connects membrane trafficking to viral restriction |
| MAP1LC3B (LC3B) | Autophagosome marker involved in autophagic degradation | Readout for autophagy-mediated viral restriction |
| BECN1 | Autophagy initiation factor contributing to viral protein degradation | Target for modulating autophagy-dependent restriction |
| CASP1 | PANoptosis component negatively regulated by A20 | Inflammatory cell death in viral infection |
| CASP8 | Apoptosis regulator influenced by viral infection | Links apoptosis to viral pathogenesis |
| BCL2 | Anti-apoptotic protein modulated by viral infections | Oncogenic and restriction-related roles |
| BAX | Pro-apoptotic effector in viral infection | Determines cell fate during restriction |
| IRF3 | Transcription factor in antiviral signaling | Post-translational modification target |
| STAT1 | Interferon signaling effector | Regulated by post-translational modifications |
| MAVS | Mitochondrial antiviral signaling adaptor | Modulated by ubiquitination and other PTMs |
| TBK1 | Kinase in antiviral signaling | Phosphorylation-dependent regulation |
How Is negative regulation of viral process Regulated?
Negative regulation of viral process is itself tightly regulated by post-translational modifications, including ubiquitination, phosphorylation, and SUMOylation, which control the stability and activity of restriction factors. A20 (TNFAIP3) provides a feedback mechanism by negatively regulating canonical NF-kB signaling, preventing excessive inflammation while still limiting viral replication. Autophagy-related proteins such as ATG14 and stress granule regulators like NS1-BP further modulate the intensity of restriction. Cell death pathways, including PANoptosis and apoptosis, are also subject to negative regulation that can either enhance or dampen viral restriction. Together, these layers ensure that negative regulation of viral process is balanced to avoid immunopathology while controlling infection.
negative regulation of viral process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TNFAIP3 (A20) | Coronavirus release and NF-kB-driven inflammation | Knockout and point-mutation cell models in porcine or human cells |
| ATG14 | Autophagy and lipid droplet turnover during viral infection | Knockout and tagged knock-in models to track lipid droplet turnover |
| IVNS1ABP (NS1-BP) | Stress granule dynamics and viral RNA fate | Knockout and overexpression models for stress granule clearance |
| NFKB1/RELA | Antiviral inflammatory signaling | Knockout and point-mutation models for NF-kB signaling |
| BCL2/BAX | Virus-associated apoptosis and oncogenesis | Overexpression and knockout models for apoptosis regulation |
Viral pathogenesis and chronic infection
Defects or viral evasion of negative regulation of viral process can lead to uncontrolled viral replication and chronic infection. Hepatitis C virus replication is a well-studied example where host restriction mechanisms determine persistence and liver disease progression. Porcine deltacoronavirus release is restricted by A20-mediated negative regulation of PANoptosis, highlighting how cell death control impacts viral spread. Post-translational modification of restriction factors is a common target for viral evasion, contributing to pathogenesis.
Virus-associated cancers
Viral infections can act as negative regulators of apoptosis and oncogenic factors, linking negative regulation of viral process to cancer development. Viruses that dysregulate apoptosis and cell death pathways can promote survival of infected cells and accumulation of oncogenic mutations. Understanding how host restriction mechanisms intersect with oncogenic signaling is critical for developing targeted therapies.
Inflammatory and immune-mediated disease
A20-mediated negative regulation of canonical NF-kB signaling is essential for preventing excessive inflammation, and its dysregulation is associated with inflammatory disease. Because negative regulation of viral process often involves NF-kB modulation, imbalances can lead to immunopathology during infection. Stress granule and autophagy dysfunction may also contribute to inflammatory responses.
From negative regulation of viral process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene a true restriction factor? | CRISPR knockout cell model followed by viral challenge |
| Does a specific phosphorylation site regulate restriction activity? | Point-mutation knock-in of phospho-dead or phospho-mimetic alleles |
| How does a restriction factor localize during infection? | Tagged knock-in with fluorescent or epitope tags |
| Does overexpression enhance viral restriction? | Doxycycline-inducible overexpression cell model |
| Which host genes are essential for negative regulation of viral process? | Genome-wide CRISPR library screening |
| How does A20 control PANoptosis during coronavirus infection? | A20 knockout and point-mutation models with PDCoV challenge |
How to Study the negative regulation of viral process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout + viral challenge | Causal role of a gene in viral restriction | Validate candidate restriction factors |
| Phosphoproteomics | Post-translational modification changes | Identify regulatory sites on restriction factors |
| Ubiquitination assays | Ubiquitin conjugation on target proteins | Study p62 and NF-kB regulation |
| Fluorescence microscopy | Localization of autophagy and stress granule markers | Visualize ATG14, LC3B, p62, NS1-BP |
| RNA-seq | Transcriptional changes during infection | Identify antiviral gene programs |
| CRISPR library screening | Genome-wide essentiality for restriction | Discover novel host restriction factors |
| Viral titer assays | Infectious virus release | Measure restriction of viral release |
| Apoptosis/PANoptosis assays | Cell death pathway activation | Study A20 and cell death regulation |
CRISPR knockout and viral challenge
CRISPR knockout of candidate restriction genes followed by viral infection is the gold standard to test causality in negative regulation of viral process. This approach can measure viral titer, genome copy number, and cell death outcomes. Knockout of A20, for example, alters PDCoV release and PANoptosis.
Post-translational modification profiling
Mass spectrometry-based proteomics and phosphoproteomics can identify modifications on host and viral proteins that regulate restriction. Ubiquitination and SUMOylation assays further validate specific modification events. These methods are essential because post-translational modifications are central to negative regulation of viral process.
Autophagy and stress granule imaging
Fluorescence microscopy of LC3B, p62, and stress granule markers can visualize autophagic and stress granule dynamics during infection. Live-cell imaging of tagged ATG14 or NS1-BP provides spatial and temporal resolution. These methods link cellular structures to viral restriction.
Transcriptomics and functional genomics
RNA-seq and CRISPR library screening can identify host genes and pathways that negatively regulate viral processes. Differential expression analysis after infection reveals restriction signatures. Functional validation by knockout or overexpression confirms hits.
How CRISPR Can Be Used to Study GO:0048525 negative regulation of viral process
Knockout
CRISPR knockout is used to delete candidate restriction genes and test whether their loss increases viral replication or release, thereby confirming their role in negative regulation of viral process. For example, A20 knockout enhances PDCoV release and PANoptosis. Knockout models are also used in genome-wide screens to identify novel restriction factors.
Point Mutation
Point-mutation knock-in models allow precise testing of post-translational modification sites, such as phospho-dead or phospho-mimetic mutations, in restriction factors. These models are critical because post-translational modifications regulate viral restriction. They can reveal whether a specific modification is required for negative regulation of viral process.
Knock-in
Tagged knock-in of genes such as ATG14 or NS1-BP enables visualization and purification of endogenous proteins during infection. This approach preserves physiological expression levels and regulatory context. Knock-in models are valuable for studying localization and dynamics of restriction factors.
Overexpression
Overexpression models, often inducible, are used to test whether increased levels of a candidate gene enhance restriction of viral processes. They can also reveal dominant-negative or gain-of-function effects. Overexpression of A20 or autophagy components can suppress viral replication and release.
How EDITGENE Supports negative regulation of viral process Research
Researchers studying negative regulation of viral process-related genes often need to determine whether a candidate gene is causally involved in restricting viral replication, release, or pathogenesis. EDITGENE provides publication-ready CRISPR cell models and screening services to accelerate this causal validation.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of viral process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| APOBEC3G Knockout HEK293 Cell Line | EDJ-KQ1894 | Human | 60489 | Details Get a Quote |
| MBL2 Knockout HEK293 Cell Line | EDJ-KQ2402 | Human | 4153 | Details Get a Quote |
| APCS Knockout HEK293 Cell Line | EDJ-KQ3397 | Human | 325 | Details Get a Quote |
| APOBEC3F Knockout HEK293 Cell Line | EDJ-KQ4453 | Human | 200316 | Details Get a Quote |
| APOBEC3G Knockout HCT 116 Cell Line | EDJ-KQ23159 | Human | 60489 | Details Get a Quote |
| APOBEC3F Knockout A-549 Cell Line | EDJ-KQ27007 | Human | 200316 | Details Get a Quote |
| APOBEC3F Knockout HCT 116 Cell Line | EDJ-KQ27008 | Human | 200316 | Details Get a Quote |
| APCS Knockout HeLa Cell Line | EDJ-KQ52627 | Human | 325 | Details Get a Quote |
| MBL2 Knockout HeLa Cell Line | EDJ-KQ53847 | Human | 4153 | Details Get a Quote |
| APOBEC3G Knockout HeLa Cell Line | EDJ-KQ56980 | Human | 60489 | Details Get a Quote |
| APOBEC3F Knockout HeLa Cell Line | EDJ-KQ59004 | Human | 200316 | Details Get a Quote |
| APCS Knockout A-549 Cell Line | EDJ-KQ61102 | Human | 325 | Details Get a Quote |
| MBL2 Knockout A-549 Cell Line | EDJ-KQ62333 | Human | 4153 | Details Get a Quote |
| APOBEC3G Knockout A-549 Cell Line | EDJ-KQ65482 | Human | 60489 | Details Get a Quote |
| APCS Knockout HCT 116 Cell Line | EDJ-KQ69589 | Human | 325 | Details Get a Quote |
Frequently Asked Questions About negative regulation of viral process
What is GO:0048525 negative regulation of viral process?
GO:0048525 is a Gene Ontology biological_process term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of a multi-organism process in which a virus is a participant.
What genes are involved in negative regulation of viral process?
Key genes include TNFAIP3 (A20), ATG14, IVNS1ABP (NS1-BP), and NF-kB pathway components such as NFKB1, RELA, and SQSTM1.
How does A20 negatively regulate viral process?
A20 restricts porcine deltacoronavirus release through negative regulation of PANoptosis and also negatively regulates canonical NF-kB signaling.
What is the role of autophagy in negative regulation of viral process?
Autophagy targets viral proteins and lipid droplets for degradation; ATG14 acts as an autophagic receptor for syntaxin18-regulated lipid droplet turnover.
How are post-translational modifications involved in viral restriction?
Phosphorylation, ubiquitination, and SUMOylation regulate the activity and stability of restriction factors and viral proteins, thereby controlling negative regulation of viral process.
What diseases are linked to negative regulation of viral process?
Dysregulation is linked to chronic viral infections such as hepatitis C, virus-associated cancers, and inflammatory diseases driven by NF-kB signaling.
How can I study negative regulation of viral process in the lab?
CRISPR knockout, point-mutation, knock-in, and overexpression models combined with viral challenge, proteomics, and imaging are standard approaches.
What is the role of stress granules in viral restriction?
NS1 binding protein regulates stress granule dynamics and clearance by inhibiting p62 ubiquitination, impacting viral RNA and protein fate.
Which viruses are restricted by A20-mediated PANoptosis regulation?
A20 restricts porcine deltacoronavirus release through negative regulation of PANoptosis.
How does hepatitis C virus relate to negative regulation of viral process?
Hepatitis C virus replication is subject to multiple host restriction mechanisms, and understanding these is critical for antiviral development.
Conclusion
GO:0048525 negative regulation of viral process provides a unified framework for understanding how host cells restrict viral life cycles through post-translational modifications, autophagy, stress granule dynamics, NF-kB signaling, and cell death regulation. Key regulators such as A20, ATG14, and NS1-BP illustrate the diversity of restriction mechanisms and their links to viral pathogenesis and disease. CRISPR-based causal models are essential to validate candidate restriction factors and to identify new therapeutic targets. Continued research into this process will inform host-directed antiviral strategies and improve our understanding of virus-host interactions.
References
- 1. Yuan Z et al.. 2024. ATG14 targets lipid droplets and acts as an autophagic receptor for syntaxin18-regulated lipid droplet turnover.. Nat Commun 15(1):631 PMID: 38245527
- 2. Chamontin C et al.. 2021. Regulation of Viral Restriction by Post-Translational Modifications.. Viruses 13(11) PMID: 34835003
- 3. Jeon P et al.. 2024. NS1 binding protein regulates stress granule dynamics and clearance by inhibiting p62 ubiquitination.. Nat Commun 15(1):10925 PMID: 39738171
- 4. Cheng CY et al.. 2014. Commentary on the regulation of viral proteins in autophagy process.. Biomed Res Int 2014:962915 PMID: 24734254
- 5. Lu C et al.. 2026. A20 restricted PDCoV release through negative regulation of PANoptosis.. mBio 17(4):e0008126 PMID: 41773863
- 6. Tabata K et al.. 2020. Hepatitis C Virus Replication.. Cold Spring Harb Perspect Med 10(3) PMID: 31570388
- 7. Pujari R et al.. 2013. A20-mediated negative regulation of canonical NF-κB signaling pathway.. Immunol Res 57(1-3):166-71 PMID: 24242761
- 8. Zamaraev AV et al.. 2020. Viral Infections: Negative Regulators of Apoptosis and Oncogenic Factors.. Biochemistry (Mosc) 85(10):1191-1201 PMID: 33202204
